Atrial Fibrillation: An Evidence-Based Approach to Comprehensive Management
Webcast
Faculty
OVERVIEW
Atrial Fibrillation: An Evidence-Based Approach to Comprehensive Management is organized by American Association of Critical - Care Nurses (AACN) and will be held during Nov 15, 2017 - Dec 31, 2019.
Accreditation :
The American Association of Critical-Care Nurses (AACN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC's) Commission on Accreditation, ANCC Provider Number 0012 (60 min contact hour). AACN has been approved as a provider of continuing education in nursing by the California State Board of Nursing, California Provider number CEP01036 for 1.2 contact hours (50 min contact hour).
Activity Summary :
Atrial fibrillation is the most common sustained cardiac arrhythmia in clinical practice and its prevalence is increasing. Atrial fibrillation is more than a rhythm disturbance and has multiple clinical implications, including hemodynamic deterioration and increased stroke risk. This session integrates the current evidence for clinical decision-making and emphasizes patient management priorities in acute care. Pharmacological and nonpharmacological approaches to the immediate and long-term management of atrial fibrillation are covered, including antiarrhythmic drugs, anticoagulants, cardioversion and ablation. Session content includes a case-based approach to clinical decision-making regarding rate versus rhythm control and long-term anticoagulation. Recent guideline updates from the American College of Cardiology, American Heart Association and Heart Rhythm Society provide evidence to support the clinical content. Pharmacology content = 75%.
Objectives :
• Differentiate between immediate and long-term treatment goals in atrial fibrillation.
• Discuss the evidence regarding rate versus rhythm control.
• Describe the decision-making process for stroke prevention in patients with atrial fibrillation.
Additional details will be posted as soon as they are available.